Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1/2 1

Status

Unknown 2Completed 2Terminated 1

Sponsor Class

OTHER 31UNKNOWN 5OTHER_GOV 2NETWORK 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 4Breast 1

Conditions

Stomach Neoplasms 4Neoplasm Metastasis 1Breast Neoplasms 1

Interventions

S 1 (combination) 12Capecitabine 11Paclitaxel 9Cisplatin 9apatinib 8Oxaliplatin 8pyrotinib 6nimotuzumab 6130-nm albumin-bound paclitaxel 6titanium silicide 5sintilimab 5camrelizumab 5anlotinib 5Etoposide 5Docetaxel 5Carboplatin 5Trastuzumab 4Radiotherapy, Intensity-Modulated 4Irinotecan 4Bevacizumab 4Albumin-Bound Paclitaxel 4nedaplatin 3Vinorelbine 3Temozolomide 3Tegafur 3Taxes 3Radiosurgery 3Gemcitabine 3Fluorouracil 3Epirubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × UNKNOWN × titanium silicide × Clear all
NCT02301481 2019-10-16

A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma

ChineseAMS

Phase 2 Completed
71 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01980810 2016-06-14

GC-A-003

ChineseAMS

Phase 2 Terminated
36 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01531452 2014-12-04

The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer

ChineseAMS

Phase 2 Completed
43 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01492543 2013-03-15

Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer

ChineseAMS

Phase 2 Unknown
30 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01747707 2012-12-12

Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer

ChineseAMS

Phase 2 Unknown
40 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡